October 30, 2014: In light of yesterday’s ouster of Sanofi CEO Christopher Viehbacher, insiders have reported that the company’s board discussed the CEO position earlier in the year with AstraZeneca CEO Pascal Soriot.
October 30, 2014: Durham, North Carolina-based Chimerix, one of the larger players in the Ebola virus therapeutics market, announced on Wednesday that it will be selling $105 million in stock as part of a $150 million shelf offering.
October 30, 2014: AstraZeneca announced today that the U.S. Food and Drug Administration has approved Xigduo XR, also known as dapagliflozin and metformin hydrochloride, for the treatment of type 2 diabetes in adults.
October 30, 2014: For established biotechs with drugs falling off the patent cliff, it was a warning shot. Biosimilars could threaten some cherished and lucrative franchises—and a annual sales numbers for 2013 from Thomson Reuters underscore that risk...